Prolonged airway activity and improved selectivity of budesonide possibly due to esterification.
about
Use of ICS/LABA (extra-fine and non-extra-fine) in elderly asthmaticsNasal retention of budesonide and fluticasone in man: formation of airway mucosal budesonide-esters in vivoDevelopment of budesonide microparticles using spray-drying technology for pulmonary administration: design, characterization, in vitro evaluation, and in vivo efficacy studyAsthma, airway biology, and allergic rhinitis in AJRCCM 2000.Inhalational Steroids and Iatrogenic Cushing's SyndromeRole of budesonide as maintenance therapy for children with asthma.Risk-benefit value of inhaled glucocorticoids: a pharmacokinetic/pharmacodynamic perspective.The role of budesonide in adults and children with mild-to-moderate persistent asthma.Optimizing inhaled corticosteroid therapy in children with chronic asthma.Once-daily inhaled budesonide for the treatment of asthma: clinical evidence and pharmacokinetic explanation.Combination inhalers containing inhaled corticosteroids and long-acting beta2-agonists: improved clinical efficacy and dosing options in patients with asthma.Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthmaBudesonide and fluticasone propionate differentially affect the airway epithelial barrierPneumonia and pneumonia related mortality in patients with COPD treated with fixed combinations of inhaled corticosteroid and long acting β2 agonist: observational matched cohort study (PATHOS)Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications.Safety considerations of inhaled corticosteroids in the elderly.Extra-fine particle inhaled corticosteroids, pharma-cokinetics and systemic activity in children with asthma.Budesonide + formoterol fumarate dihydrate for the treatment of asthma.Rehydrated sterically stabilized phospholipid nanomicelles of budesonide for nebulization: physicochemical characterization and in vitro, in vivo evaluations.Increased glycosaminoglycans in the urine of asthmatic children on inhaled corticosteroids.Risk of pneumonia with budesonide-containing treatments in COPD: an individual patient-level pooled analysis of interventional studies.Gut mucosal uptake and retention characteristics contribute to the high intestinal selectivity of budesonide compared with prednisolone in the rat.Once-daily administration of budesonide Turbuhaler was as effective as twice-daily treatment in patients with mild to moderate persistent asthma.Comparison of different dosing strategies of intratracheally instilled budesonide on meconium injured piglet lungs.Budesonide/salmeterol in fixed-dose combination for the treatment of asthma.Real-world effects of two inhaled corticosteroid/long-acting β₂-agonist combinations in the treatment of asthma.
P2860
Q28066822-4314D4BF-EE9C-4F6D-AE83-438FD09529DFQ28361021-25BF2845-5228-4841-8EA1-75E0BF43F6F3Q33573525-A8048EE8-1F1F-4669-8562-F62ED43C7AB5Q34446626-D82C4511-C5B4-463F-9C75-54A6FFDFC492Q35056151-D4B3901D-B20E-455D-BFB4-2FA46ED964C9Q35138776-76648862-9577-4AAA-9309-CF0A6FFFDD96Q35610011-D06E37A0-1045-4141-A7EE-C415D7FC43A2Q35716906-63A7CF0D-6593-442E-A39F-C0CB4C0F6419Q35942577-70589AE6-1D5E-4F10-B241-60C021D4979FQ36005008-8E364BC8-06D6-49DC-8C58-7D44E43635CCQ36326508-10B9FE8C-3A39-4A32-8E0A-3A2B5783D891Q36432119-8A24595C-7772-444A-8E41-00C15122A260Q36439199-022A14A2-F462-40CA-BF52-408759759231Q36883006-CB34C406-1700-4267-83D3-F28C7F6FC1D4Q37265119-31DC441C-3E8B-4FEE-B7E8-97B2A6ED3FAAQ38248458-28B00B7B-F7B7-45B5-B73E-AA6C3F298706Q38584947-EAB66E68-89FE-40C5-A467-62AECE91E0A6Q38806274-CA0278D8-0687-4C2C-9C6D-3FE2A7F0AF1AQ38885341-BEF782EA-5512-4F6C-BBAA-E97965013E33Q39351796-DCC9B448-B8E6-4FFF-AAC2-9C869589412FQ42124677-0EE4B7C4-BCDD-4648-8E0C-D64ADD0A4895Q43817676-365471FB-E08F-4A65-A284-CD668C10D5A9Q44013886-232D0125-E101-4B9D-948C-3793AE0B7211Q47858448-4428CAC0-5DB7-4D1B-BEC9-0598A69E2C1DQ51602950-1009A099-A32C-483A-A8C9-BE0390B1E0FDQ53593298-F5D76F42-F6C9-4D3E-847C-02AF3E6E5D91
P2860
Prolonged airway activity and improved selectivity of budesonide possibly due to esterification.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Prolonged airway activity and ...... ossibly due to esterification.
@en
Prolonged airway activity and ...... ossibly due to esterification.
@nl
type
label
Prolonged airway activity and ...... ossibly due to esterification.
@en
Prolonged airway activity and ...... ossibly due to esterification.
@nl
prefLabel
Prolonged airway activity and ...... ossibly due to esterification.
@en
Prolonged airway activity and ...... ossibly due to esterification.
@nl
P2093
P2860
P1476
Prolonged airway activity and ...... ossibly due to esterification.
@en
P2093
Brattsand R
Miller-Larsson A
Runström A
P2860
P304
P356
10.1164/AJRCCM.162.4.9806112
P407
P433
P577
2000-10-01T00:00:00Z